Related Experiment Video

Updated: Jun 26, 2026

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
07:04

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

PDGF-D signaling: a novel target in cancer therapy

Zhiwei Wang1, Dejuan Kong, Yiwei Li

  • 1Department of Pathology, Karmanos Cancer Institute, Wayne State University, Detroit, Michigan, USA.

Current Drug Targets
|January 20, 2009
PubMed

Insights

Platelet-derived growth factor-D (PDGF-D) is a new growth factor. Its role in cancer progression and metastasis is explored, highlighting the PDGF-D signaling pathway

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Platelet-derived growth factor-D (PDGF-D) is a recently identified growth factor.
  • PDGF-D regulates cellular processes like proliferation, transformation, invasion, and angiogenesis.
  • It functions by activating the PDGFR-beta receptor.

Purpose of the Study:

  • To investigate the largely unknown functions of PDGF-D in human cancer progression.
  • To discuss the role of the PDGF-D signaling pathway in cancer development.
  • To explore how PDGF-D deregulation contributes to tumor development and metastasis.

Main Methods:

  • Literature review and discussion of existing research on PDGF-D.
  • Analysis of the PDGF-D signaling pathway in the context of cancer.
  • Examination of the link between PDGF-D deregulation and metastatic disease.

Main Results:

  • PDGF-D plays a significant role in regulating cellular processes relevant to cancer.
  • The PDGF-D signaling pathway is implicated in tumor development.
  • Deregulation of PDGF-D is associated with the progression to metastatic disease.

Conclusions:

  • The PDGF-D signaling pathway is a critical factor in human cancer.
  • Understanding PDGF-D's role is essential for comprehending tumor development and metastasis.
  • Further research into PDGF-D is warranted for potential therapeutic strategies.

More Related Videos

Mimicking the Function of Signaling Proteins: Toward Artificial Signal Transduction Therapy12:24

Mimicking the Function of Signaling Proteins: Toward Artificial Signal Transduction Therapy

Published on: September 29, 2016

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures07:48

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Published on: December 26, 2016

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...